content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

ReNeuron Group PLC (RENE.L)

1.69
-0.03
(-2.03%)
Sep 11, 4:35PM EDT
content_middle

Reneuron (RENE.L)  is a stem cell research company whose focus is on therapies targeting areas of poorly met medical need, including peripheral arterial disease, stroke, and retinal diseases.  RENE is currently testing the effects of neural stem cells on spines for neuroregeneration, and is testing the use of fetal stem cells on stroke patients.

A UK company, used as a scientific comparable due to status of trials and disease state.

Previous Close: 
1.73
Open: 
1.73
Bid: 
N/A
Ask: 
N/A
1yr Target Price: 
N/A
Day's Range: 
1.69 - 1.70
52wk Range: 
1.65 - 3.67
Volume: 
720000
Average Daily Volume: 
2885930
Market Capitalization: 
53.48M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
3164618000M
content_right

Pages